See Asa at Microbiome & Probiotic R&D & Business Collaboration Forum - La Jolla, California 10/13/2025
December 15, 2021 By: Asa Waldstein

Learning Targets: definition of supplements, safety claims, disease statements

Takeaway -

Before marketing products check with a supplement expert

Today’s Warning Letter Wednesday is cringeworthy but also contains learning lessons for product marketers and developers.

The product is a vape that contains caffeine, is labeled as a supplement, makes overt safety claims, and uses high risk marketing disease claims. There are a lot of learning lessons here.

Vapes by definition are very high risk. Adding caffeine into a smokable product with other herbal ingredients may seem like a good idea to an untrained development team, but it is actually exceptionally dangerous.

Supplements are defined as products taken by mouth that contain a “dietary ingredient” intended to supplement the diet. Smokable products by definition cannot be supplements because they are not ingested. As a side comment this is also why “sublingual” delivery is not suitable for supplements, as it’s a drug delivery term.

I ask, what regulatory category does a vape with herbal ingredients belong to?

Making safety claims on any product must be substantiated. When statements like this are made it seems more like optimistic and potentially deceptive marketing than hard science:

From warning letter: “Is it safe to inhale caffeine?…..Yes”

There are also high risk marketing disease claims mentioned in this warning letter. These include references to “inflammation” which I discussed in last week’s Warning Letter Wednesday here.

Lots of claims here discuss ingredient benefits such as:

From warning letter: “Vitamin B12 has even more science-based health benefits including:….Supporting bone health and preventing osteoporosis…Uplifting mood and symptoms of depression”

I review ingredient benefit claims in another Warning Letter Wednesday here.

Read the full warning letter here.

Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading.

Written by

Asa Waldstein
Asa Waldstein
Asa Waldstein is a 24-year veteran of the dietary supplement industry, with experience spanning manufacturing, marketing, and regulatory compliance. He is the principal of Apex Compliance, a software company dedicated to streamlining regulatory marketing compliance for the dietary supplement and natural products sectors. Asa also leads Supplement Advisory Group, a boutique consultancy focused on marketing risk analysis, labeling, and practical compliance strategies for websites and social media. Asa has helped oversee three FDA GMP inspections with no 483s and was honored with the 2023 AHPA Herbal Hero Award and the 2024 What's Up Supps Policy and Change Agent Award. He currently serves as Chair of the American Herbal Products Association’s (AHPA) Cannabis Committee, helping shape policy and industry best practices